Inj cladribine per 1 mg
Products billed under this code include Cladribine.
Payment limit per 1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Cladribine.
Payment limit per 1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Cladribine | Hikma Pharmaceuticals USA Inc. | 00143-9871-01 | 10 | $78.72 |
| Cladribine | Hisun Pharmaceuticals USA, Inc | 42658-0010-01 | 10 | $78.72 |
| Cladribine | Hisun Pharmaceuticals USA, Inc | 42658-0010-91 | 10 | $78.72 |
| Cladribine | FreseniUS Kabi USA, LLC | 63323-0140-10 | 10 | $78.72 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $7.872 | −$0.316 | 1 MG | Inj cladribine per 1 mg | v1, posted September 17, 2026 |
| 3Q26 | $8.188 | −$0.538 | 1 MG | Inj cladribine per 1 mg | v1, posted September 15, 2026 |
| 2Q26 | $8.726 | +$1.307 | 1 MG | Inj cladribine per 1 mg | v1, posted September 15, 2026 |
| 1Q26 | $7.419 | −$3.259 | 1 MG | Inj cladribine per 1 mg | v1, posted September 15, 2026 |
| 4Q25 | $10.678 | +$0.952 | 1 MG | Inj cladribine per 1 mg | v1, posted September 8, 2026 |
| 3Q25 | $9.726 | −$0.476 | 1 MG | Inj cladribine per 1 mg | v1, posted March 10, 2026 |
| 2Q25 | $10.202 | −$1.068 | 1 MG | Inj cladribine per 1 mg | v1, posted March 10, 2026 |
| 1Q25 | $11.27 | −$2.975 | 1 MG | Inj cladribine per 1 mg | v1, posted December 19, 2025 |
| 4Q24 | $14.245 | +$0.97 | 1 MG | Inj cladribine per 1 mg | v1, posted June 11, 2025 |
| 3Q24 | $13.275 | −$3.322 | 1 MG | Inj cladribine per 1 mg | v1, posted June 11, 2025 |
| 2Q24 | $16.597 | +$0.824 | 1 MG | Inj cladribine per 1 mg | v1, posted March 11, 2025 |
| 1Q24 | $15.773 | −$0.984 | 1 MG | Inj cladribine per 1 mg | v1, posted December 19, 2024 |
| 4Q23 | $16.757 | −$1.539 | 1 MG | Inj cladribine per 1 mg | v1, posted October 10, 2024 |
| 3Q23 | $18.296 | −$0.58 | 1 MG | Inj cladribine per 1 mg | v1, posted June 5, 2024 |
| 2Q23 | $18.876 | −$4.161 | 1 MG | Inj cladribine per 1 mg | v1, posted February 23, 2024 |
| 1Q23 | $23.037 | −$1.268 | 1 MG | Inj cladribine per 1 mg | v1, posted December 6, 2023 |
| 4Q22 | $24.305 | +$2.647 | 1 MG | Inj cladribine per 1 mg | v1, posted June 22, 2023 |
| 3Q22 | $21.658 | +$3.962 | 1 MG | Inj cladribine per 1 mg | v1, posted June 9, 2023 |
| 2Q22 | $17.696 | +$2.612 | 1 MG | Inj cladribine per 1 mg | v1, posted December 14, 2022 |
| 1Q22 | $15.084 | −$2.939 | 1 MG | Inj cladribine per 1 mg | v1, posted June 8, 2022 |
| 4Q21 | $18.023 | −$0.656 | 1 MG | Inj cladribine per 1 mg | v1, posted June 2, 2022 |
| 3Q21 | $18.679 | −$0.936 | 1 MG | Inj cladribine per 1 mg | v1, posted June 2, 2022 |
| 2Q21 | $19.615 | −$1.408 | 1 MG | Inj cladribine per 1 mg | v1, posted March 1, 2022 |
| 1Q21 | $21.023 | – | 1 MG | Inj cladribine per 1 mg | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.